Remote Early Detection of SARS-CoV-2 infections

niversitair Medisch Centrum Utrecht (UMCU), Julius Center0 个研究点目标入组 20,000 人开始时间: 待定最近更新: 2024年2月28日

试验速览

暂无简介。

•Resident of the Netherlands
•At least 18 years old
•Informed consent provided (electronic)
•Willing to adhere to the study procedures described in this protocol
•Must have a smartphone that runs at least Android 8.0 or iOS 13.0 operating systems and is active for the duration of the study (in the case of a change of mobile number, study team should be notified)
•Be able to read, understand and write Dutch

•Previous positive SARS-CoV-2 test result (confirmed either through PCR/antigen or antibody tests) (self-reported)
•Previously received a vaccine developed specifically for COVID-19 or in possession of an appointment for vaccination in the near future
•Current suspected (e.g. waiting for test result) coronavirus infection or symptoms of a coronavirus infection (self-reported)
•Participating in any other COVID-19 clinical drug, vaccine, or medical device trial
•Electronic implanted device (such as a pacemaker)
•Pregnant at time of informed consent (self-reported)
•Suffering from cholinergic urticaria (per the Ava bracelet’s User Manual)
•Staff involved in the management or conduct of this study

发起方

niversitair Medisch Centrum Utrecht (UMCU), Julius Center